Non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in living-donor liver transplantation (LDLTX)

被引：0
|
作者：
Yamamoto, K [1 ]
Takada, Y [1 ]
Fujimoto, Y [1 ]
Haga, H [1 ]
Egawa, H [1 ]
Tanaka, K [1 ]
机构：
[1] Kyoto Univ, Dept Transplanta & Immunol, Kyoto, Japan
来源：
LIVER TRANSPLANTATION | 2004年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
116
引用
收藏
页码：C29 / C29
页数：1
相关论文
共 50 条
  • [31] A National Survey of Physicians Regarding Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH): The Disease and Clinical Trial Awareness Program for NASH
    Younossi, Zobair M.
    Stepanova, Maria
    Saenz, Thomas
    Cooper, Gayle
    Schmidt, Christa
    Petruccelli, Steve
    HEPATOLOGY, 2017, 66 : 1184A - 1184A
  • [32] Predictive Value of ALT for Diagnosing Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
    Verma, Siddharth
    Sharma, Prashant
    Hart, John
    Mohanty, Smruti R.
    GASTROENTEROLOGY, 2012, 142 (05) : S1019 - S1020
  • [33] HLA Class II Alleles Are Strongly Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Fibrosis
    Karrar, Azza
    Li, Zheng
    Moosvi, Ali M.
    Hariharan, Siddharth
    Fang, Yun
    Stepanova, Maria
    Goodman, Zachary D.
    Younossi, Zobair
    HEPATOLOGY, 2014, 60 : 601A - 602A
  • [34] Independent Predictors of Non-alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in a Large Cohort of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Fang, Yun
    Rafiq, Nila
    Afendy, Mariam
    Younossi, Youssef
    Lam, Brian
    Goodman, Zachary
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S120 - S120
  • [35] Components of Metabolic Syndrome and the Rising Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States
    Stepanova, Maria
    Afendy, Mariam
    Vernon, Gregory C.
    Nader, Fatema
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2011, 140 (05) : S988 - S988
  • [36] Melanocortins and Interleukins Contributing to Advanced Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in Patients With BMI ≥ 40
    Baranova, Ancha
    Jarrar, Mohammed
    Moazzez, Amir H.
    Elariny, Hazem
    Abawi, Massih
    Wang, Lei
    Afendy, Arian
    Stepanova, Maria
    Estep, J. M.
    Younossi, Zobair M.
    OBESITY, 2011, 19 : S87 - S87
  • [37] Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
    Younossi, Zobair M.
    Yilmaz, Yusuf
    Yu, Ming-Lung
    Wong, Vincent Wai-Sun
    Fernandez, Marlen Castellanos
    Isakov, Vasily A.
    Duseja, Ajay K.
    Mendez-Sanchez, Nahum
    Eguchi, Yuichiro
    Bugianesi, Elisabetta
    Burra, Patrizia
    George, Jacob
    Fan, Jian-Gao
    Papatheodoridis, George, V
    Chan, Wah Kheong
    Alswat, Khalid
    Saeed, Hamid S.
    Singal, Ashwani K.
    Romero-Gomez, Manuel
    Gordon, Stuart C.
    Roberts, Stuart K.
    El Kassas, Mohamed
    Kugelmas, Marcelo
    Ong, Janus P.
    Alqahtani, Saleh
    Ziayee, Mariam
    Lam, Brian
    Younossi, Issah
    Racila, Andrei
    Henry, Linda
    Stepanova, Maria
    Council, Global Nash
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2296 - 2306
  • [38] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [39] Non-alcoholic fatty liver disease and steatohepatitis
    Par Gabriella
    Horvath Gabor
    Par Alajos
    ORVOSI HETILAP, 2013, 154 (29) : 1124 - 1134
  • [40] Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Drescher, Hannah K.
    Weiskirchen, Sabine
    Weiskirchen, Ralf
    CELLS, 2019, 8 (08)
12345